Steven Lichtman

Stock Analyst at Oppenheimer

(2.06)
# 1314
Out of 5,231 analysts
74
Total ratings
53.33%
Success rate
24.97%
Average return
20 Stocks
Name Action Price Target Current % Upside Ratings Updated
DexCom
Maintains: Outperform
115 105
86.43 21.49% 8 Oct 25, 2024
Zimmer Biomet Holdin...
Maintains: Outperform
145 135
111.23 21.37% 7 Oct 15, 2024
MannKind
Maintains: Outperform
10 12
6.12 96.08% 2 Aug 28, 2024
Alcon
Maintains: Outperform
103 110
91.42 20.32% 3 Aug 22, 2024
Medtronic
Maintains: Perform
92 94
91.5 2.73% 10 Aug 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
72 65
31.6 105.7% 8 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
47 58
36.31 59.74% 1 Jun 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 11
10.42 5.57% 5 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
12
12.46 -3.69% 2 Apr 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
82 87
108.51 -19.82% 1 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
58 68
102.79 -33.85% 2 Feb 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
4
1.26 177.78% 2 Sep 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 9 May 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
300 275
277.1 -0.76% 3 Jan 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
273 288
390.91 -26.33% 1 Jul 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
105
158.86 -33.9% 3 Jul 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Perform
150
24.25 518.56% 1 Jul 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
83 85
98 -13.27% 2 Sep 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Dec 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Apr 12, 2017